Vavilovskii Zhurnal Genetiki i Selektsii, with ISSN 2500-0462 and E-ISSN 2500-3259, is a distinguished open-access journal published by the Russian Academy of Sciences, Institute of Cytology and Genetics. Since transitioning to open access in 2013, the journal has been dedicated to advancing research and discourse in the fields of genetics and selection, particularly within agricultural and biological sciences. With a current ranking of Q2 in Agricultural and Biological Sciences and Q3 in Biochemistry, Genetics and Molecular Biology according to Scopus, it serves as a pivotal platform for researchers, professionals, and students to disseminate their findings and collaborate on innovative ideas. The journal, housed in the vibrant academic environment of Novosibirsk, Russia, publishes a diverse range of articles that contribute to the ongoing evolution of genetic studies and practical applications in agriculture. Its commitment to quality and accessibility ensures it plays an essential role in the global scientific community, fostering knowledge that bridges theoretical research and practical implementation.

GENES & GENETIC SYSTEMS, an esteemed journal published by the Genetics Society of Japan, serves as a vital platform for the dissemination of innovative research within the fields of genetics, molecular biology, and medicine. Established in 1996 and based in Mishima, Shizuoka, Japan, this journal has actively contributed to the academic community, fostering collaboration and knowledge sharing among researchers and professionals. The journal’s impact can be seen through its category quartiles, which reflect its position in Genetics, Molecular Biology, and Medicine, and while it currently ranks in Q4 in Genetics and Q3 in Medicine (miscellaneous), it is poised for growth as it continues to publish pivotal studies. With a commitment to open access, GENES & GENETIC SYSTEMS ensures that research findings are freely accessible to the global scientific community, promoting a more inclusive approach to knowledge distribution. This journal is essential for students, researchers, and professionals seeking to stay informed of advancements in genetic research and its implications for the broader field of medicine.

JOURNAL OF NEUROGENETICS, published by Taylor & Francis Ltd in the United Kingdom, is an influential platform for research and discussion in the dynamic field of neurogenetics. With an ISSN of 0167-7063 and an E-ISSN of 1563-5260, this journal has been committed to advancing our understanding of the genetic underpinnings of neurological conditions since its inception in 1983. Presently categorized in the Q3 quartile for Cellular and Molecular Neuroscience and Q2 for Genetics as of 2023, it serves as an essential resource for researchers and professionals seeking insights into the genetic factors influencing nervous system function and disorder. Although it does not offer open access, the journal remains a critical repository of knowledge with a broad scope that invites contributions spanning molecular genetics to neurobiology. With its rankings in Scopus reflecting a keen focus on robust academic standards, the JOURNAL OF NEUROGENETICS is vital for those dedicated to pioneering research and finding solutions in neurogenetics, making it a significant asset to students, scholars, and industry experts alike.

HUMAN MOLECULAR GENETICS, published by Oxford University Press, is a premier journal in the field of genetics, with an established reputation since its inception in 1992. With an impressive Q1 ranking in various categories, including Genetics, Clinical Genetics, and Molecular Biology, this journal engages a diverse readership by reporting significant advances in our understanding of the genetic basis of human health and disease. The journal has achieved notable rankings within Scopus, particularly in Clinical Genetics, making it a key resource for professionals and researchers aiming to stay at the forefront of genetic research. Although it operates under a traditional access model, it remains committed to disseminating high-quality research that informs clinical practice and enhances knowledge in the genetic field. The journal's impact factor signifies its crucial role in shaping contemporary genetic research and its application in medicine. As the field continues to evolve, HUMAN MOLECULAR GENETICS serves not only as an academic repository but also as a vital platform for innovation and discussion among students, researchers, and clinicians.

NATURE REVIEWS GENETICS, published by NATURE PORTFOLIO, stands as a leading journal in the field of genetics, boasting a remarkable reputation reflected in its Q1 ranking across multiple categories including Genetics, Clinical Genetics, and Molecular Biology. With an impressive percentile of 99th in both Genetics and Clinical Genetics, as well as a solid rank in Molecular Biology, this journal is pivotal for researchers, professionals, and students alike who seek to stay informed on the latest advancements and comprehensive reviews in genetic research. The journal's scope encompasses a wide array of topics, providing in-depth insights from fundamental genetic principles to clinical applications, underscoring its importance in bridging basic science and medical practice. Though not an open-access publication, it remains accessible through various academic institutions, enhancing its reach and influence within the scientific community. With publication years spanning from 2000 to 2024, NATURE REVIEWS GENETICS continues to shape the future of genetics research and education.

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

JOURNAL OF BIOSCIENCES, published by the Indian Academy of Sciences, has established itself as a pioneering platform in the fields of biosciences, encompassing diverse research areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and medicine. With an impressive trajectory since its inception in 1979, the journal has achieved notable recognition, securing a Q1 ranking in Agricultural and Biological Sciences and maintaining its place in the top quartiles for Biochemistry and Medicine as of 2023. With Scopus rankings placing it at #32 in General Agricultural and Biological Sciences and #65 in General Biochemistry, Genetics, and Molecular Biology, the journal reaches the 85th and 70th percentiles respectively, reflecting its impact and relevance in current scientific discourse. Although it does not offer open access, the JOURNAL OF BIOSCIENCES remains crucial for researchers, professionals, and students dedicated to advancing knowledge and innovation within the biosciences, providing a vibrant forum for high-quality research and comprehensive reviews.

GENETICS AND MOLECULAR RESEARCH is a distinguished academic journal published by FUNPEC-EDITORA, focusing on the rapidly evolving fields of genetics and molecular biology. Since its inception in 2002, the journal has provided a platform for high-quality research and advancements that contribute to our understanding of genetic mechanisms and molecular interactions. With an impressive convergence period extending through 2024, this open-access journal presents vital insights while maintaining accessibility for researchers, professionals, and students alike. Though currently positioned in the Q4 quartile in Genetics, Medicine (Miscellaneous), and Molecular Biology as per the latest 2023 rankings, its persistent publication efforts aim to elevate its influence within the academic community. Researchers are invited to explore groundbreaking studies that may inform future developments in these critical scientific domains.

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

Human Gene is an innovative open access journal published by ELSEVIER, dedicated to the ever-evolving field of genetics. Established in 2022, this journal serves as a vital resource for researchers, professionals, and students alike, aiming to facilitate the dissemination of groundbreaking research and advancements in both basic and clinical genetics. With an ISSN of 2773-0441, Human Gene focuses on providing a platform for high-quality studies that investigate genetic mechanisms, their implications in health and disease, and novel therapeutic strategies. The journal currently holds a Q4 ranking in both Genetics and Clinical Genetics categories, reflecting its emerging status within the scientific community, and strives to enhance its impact to better serve an engaged audience. With its base in Amsterdam, Netherlands, Human Gene is committed to making research accessible through its open access model, inviting contributions that advance our understanding of human genetics and foster collaboration across disciplines.